Latest & greatest articles for otitis media

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on otitis media or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on otitis media and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for otitis media

121. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. (PubMed)

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Acute otitis media is one of the most commonly-diagnosed childhood infections. This study assessed the efficacy of a novel vaccine that contained polysaccharides from 11 different Streptococcus pneumoniae serotypes each conjugated to Haemophilus influenzae-derived protein D (...) in prevention of acute otitis media.4968 infants were randomly assigned to receive either pneumococcal protein D conjugate or hepatitis A vaccine at the ages of 3, 4, 5, and 12-15 months and were followed-up until the end of the second year of life. Middle-ear fluid was obtained for bacteriological culture and serotyping in children who presented with abnormal tympanic membrane or presence of middle-ear effusion, plus two predefined clinical symptoms. The primary endpoint was protective efficacy against

2006 Lancet Controlled trial quality: predicted high

122. Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial. (PubMed)

Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial. Acute otitis media (AOM) is the most common diagnosis for which antibiotics are prescribed for children. Previous trials that have evaluated a "wait-and-see prescription" (WASP) for antibiotics, with which parents are asked not to fill the prescription unless the child either is not better or is worse in 48 hours, have excluded children with severe AOM. None of these trials were conducted

Full Text available with Trip Pro

2006 JAMA Controlled trial quality: predicted high

123. Review: antibiotics are moderately effective for acute otitis media in children

Review: antibiotics are moderately effective for acute otitis media in children Review: antibiotics are moderately effective for acute otitis media in children | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: antibiotics are moderately effective for acute otitis media in children Article Text Treatment Review: antibiotics are moderately effective for acute otitis media in children Free Stephanie Wright , RN, PhD, CFNP, CPNP

Full Text available with Trip Pro

2005 Evidence-Based Nursing

124. Review: ear pain and a cloudy, bulging, or distinctly immobile tympanic membrane appear to help diagnose acute otitis media in children

Review: ear pain and a cloudy, bulging, or distinctly immobile tympanic membrane appear to help diagnose acute otitis media in children Review: ear pain and a cloudy, bulging, or distinctly immobile tympanic membrane appear to help diagnose acute otitis media in children | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies (...) media in children Article Text Diagnosis Review: ear pain and a cloudy, bulging, or distinctly immobile tympanic membrane appear to help diagnose acute otitis media in children Free Matti Uhari , MD, MSc Statistics from Altmetric.com Rothman R, Owens, Simel DL. Does this child have acute otitis media? JAMA 2003 ; 290 : 1633 –40. Q In children, how accurate are symptoms and signs for diagnosing acute otitis media (AOM)? Clinical impact ratings GP/FP/Primary care ★★★★☆☆☆ Emergency medicine ★★★★★

Full Text available with Trip Pro

2005 Evidence-Based Medicine (Requires free registration)

125. Antibiotic treatment for otitis media in children

Antibiotic treatment for otitis media in children Antibiotic treatment for otitis media in children Antibiotic treatment for otitis media in children Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Antibiotic treatment for otitis media in children. Lansdale: HAYES, Inc.. Directory Publication. 2005 Authors' objectives Otitis media (OM) is a spectrum of diseases (...) MeSH Child; Otitis Media /drug therapy Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo@hayesinc.com AccessionNumber 32006000084 Date bibliographic record published 02/02/2006 Date abstract record published 12/05/2010 Health Technology Assessment (HTA) database Copyright © 2019

2005 Health Technology Assessment (HTA) Database.

126. EarPopper for the treatment of otitis media with effusion in children

EarPopper for the treatment of otitis media with effusion in children 0 National Horizon Scanning Unit Horizon scanning prioritising summary Volume 11, Number 4: EarPopper ™ for the treatment of otitis media with effusion in children. December 2005 1 © Commonwealth of Australia 2005 This work is copyright. You may download, display, print and reproduce this material in unaltered form only (retaining this notice) for your personal, non-commercial use or use within your organisation. Apart from (...) Scanning Unit, Adelaide Health Technology Assessment, Department of Public Health, Mail Drop 511, University of Adelaide, South Australia, 5005 2 PRIORITISING SUMMARY REGISTER ID: 000178 NAME OF TECHNOLOGY: EARPOPPER ™ PURPOSE AND TARGET GROUP: TREATMENT OF OTITIS MEDIA WITH EFFUSION IN CHILDREN STAGE OF DEVELOPMENT (IN AUSTRALIA): ? Yet to emerge Established Experimental Established but changed indication or modification of technique Investigational Should be taken out of use Nearly established

2005 Australia and New Zealand Horizon Scanning Network

127. Cost-utility analysis of tympanomastoidectomy for adults with chronic suppurative otitis media

Cost-utility analysis of tympanomastoidectomy for adults with chronic suppurative otitis media Cost-utility analysis of tympanomastoidectomy for adults with chronic suppurative otitis media Cost-utility analysis of tympanomastoidectomy for adults with chronic suppurative otitis media Wang P C, Jang C H, Shu Y H, Tai C J, Chu K T Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study evaluated tympanomastoid surgery. A comparator was not explicitly stated at the outset, although it was likely to be no tympanomastoid surgery. The health technology was compared between two different patient groups. These were patients with wet ear suffering from chronic suppurative otitis media (CSOM) and patients with dry ear

2005 NHS Economic Evaluation Database.

128. Grommets in otitis media with effusion: an individual patient data meta-analysis

Grommets in otitis media with effusion: an individual patient data meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

129. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment

Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 NHS Economic Evaluation Database.

130. Otitis media. (PubMed)

Otitis media. Otitis media (OM) continues to be one of the most common childhood infections and is a major cause of morbidity in children. The pathogenesis of OM is multifactorial, involving the adaptive and native immune system, Eustachian-tube dysfunction, viral and bacterial load, and genetic and environmental factors. Initial observation seems to be suitable for many children with OM, but only if appropriate follow-up can be assured. In children younger than 2 years with a certain diagnosis

2004 Lancet

131. Pneumococcal vaccines for preventing otitis media. (PubMed)

Pneumococcal vaccines for preventing otitis media. Acute otitis media (AOM) is one of the most common diseases in early infancy and childhood. Long term effects of recurrent episodes of otitis media, rapid emergence of drug resistant bacteria associated with AOM worldwide and huge estimated direct and indirect annual costs associated with otitis media have emphasized the need for an effective vaccination program to prevent episodes of AOM.The object of this review was to assess the effect

2004 Cochrane

132. Adenoidectomy versus chemoprophylaxis and placebo for recurrent acute otitis media in children aged under 2 years: randomised controlled trial. (PubMed)

Adenoidectomy versus chemoprophylaxis and placebo for recurrent acute otitis media in children aged under 2 years: randomised controlled trial. To evaluate the efficacy of adenoidectomy compared with long term chemoprophylaxis and placebo in the prevention of recurrent acute otitis media in children aged between 10 months and 2 years.Randomised, double blind, controlled trial.Oulu University Hospital, a tertiary centre in Finland.180 children aged 10 months to 2 years with recurrent acute (...) otitis media.Adenoidectomy, sulfafurazole (sulphisoxazole) 50 mg/kg body weight, given once a day for six months or placebo. Follow up lasted for two years, during which time all symptoms and episodes of acute otitis media were recorded.Intervention failure (two episodes in two months or three in six months or persistent effusion) during follow up, number of episodes of acute otitis media, number of visits to a doctor because of any infection, and antibiotic prescriptions Number of prescriptions

Full Text available with Trip Pro

2004 BMJ Controlled trial quality: predicted high

133. Does this child have acute otitis media? (PubMed)

Does this child have acute otitis media? Acute otitis media (AOM) is one of the most common problems in pediatrics. An accurate diagnosis of AOM can guide proper treatment and follow-up.To systematically review the literature regarding precision and accuracy of history taking and physical examination in diagnosing AOM in children.We searched MEDLINE for English-language articles published from 1966 through May 2002. Bibliographies of retrieved articles and textbooks were also searched.We (...) LR, 8.4; 95% CI, 6.7-11) whereas a normal color makes AOM much less likely (adjusted LR, 0.2; 95% CI, 0.19-0.21).Although many of the studies included in this analysis are limited by bias, a cloudy, bulging, or clearly immobile tympanic membrane is most helpful for detecting AOM. The degree of erythema may also be useful since a normal color makes otitis media unlikely whereas a distinctly red tympanic membrane increases the likelihood significantly.

2003 JAMA

134. Screening children in the first four years of life to undergo early treatment for otitis media with effusion. (PubMed)

Screening children in the first four years of life to undergo early treatment for otitis media with effusion. Otitis media with effusion (OME) is the most common cause of acquired hearing loss in childhood and has been associated with delayed language development and behavioural problems. This condition has a prevalence of about 20% at the age of two years, a time of rapid language development. It is most often asymptomatic. Effective treatment exists for clearing effusions. Some have argued

2003 Cochrane

135. Diagnosis, natural history, and late effects of otitis media with effusion

Diagnosis, natural history, and late effects of otitis media with effusion Diagnosis, natural history, and late effects of otitis media with effusion Diagnosis, natural history, and late effects of otitis media with effusion Shekelle P, Takata G, Chan L S, Mangione-Smith R, Corley PM, Morphew T, Morton S Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA (...) database. Citation Shekelle P, Takata G, Chan L S, Mangione-Smith R, Corley PM, Morphew T, Morton S. Diagnosis, natural history, and late effects of otitis media with effusion. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Report/Technology Assessment No. 55. 2003 Authors' objectives The purpose of this evidence-based report is to review the evidence on the natural history of otitis media with effusion (OME), the late effects of early life otitis media on hearing and speech

2003 Health Technology Assessment (HTA) Database.

136. Does this child have acute otitis media?

Does this child have acute otitis media? Does this child have acute otitis media? Does this child have acute otitis media? Rothman R, Owens T, Simel D L CRD summary This review assessed history taking and physical examination in the diagnosis of acute otitis media in children. The authors concluded that although many studies had methodological limitations, a cloudy, bulging or clearly immobile tympanic membrane is highly suggestive of acute otitis media. The conclusions were based on poor (...) -quality studies and may not be reliable. Authors' objectives To assess the precision and accuracy of history taking and physical examination in the diagnosis of acute otitis media (AOM) in children. Searching MEDLINE was searched from inception to May 2002 for studies published in English. The bibliographies of selected studies and general and specialist textbooks were also checked. Study selection Study designs of evaluations included in the review Studies that used a nonindependent comparison

2003 DARE.

137. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. (PubMed)

Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Pneumococcal conjugate vaccine prevents recurrent acute otitis media (AOM) in infants immunised at 2, 4, 6, and 12-15 months of age. We aimed to find out whether this vaccine also prevents AOM in older children who have had previous episodes of AOM.In this double-blind, randomised study, we enrolled 383 patients aged 1-7 years who had had two or more (...) to the use of pneumococcal conjugate vaccine to prevent otitis media in previously unvaccinated toddlers and children with a history of recurrent AOM.

2003 Lancet Controlled trial quality: predicted high

138. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. (PubMed)

Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. Acute otitis media (AOM) frequently complicates influenza infection. Previous studies have found influenza vaccine effective in reducing the occurrence of AOM in children mainly older than 2 years.To evaluate the effectiveness of inactivated influenza vaccine in preventing AOM in children aged 6 to 24 months.Randomized, double-blind, placebo-controlled trial of 786

Full Text available with Trip Pro

2003 JAMA Controlled trial quality: predicted high

139. Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. (PubMed)

Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. Chronic otitis media with effusion (OME) has long been considered to be a sterile inflammatory process. The previous application of molecular diagnostic technologies to OME suggests that viable bacteria are present in complex communities known as mucosal biofilms; however, direct imaging evidence of mucosal biofilms associated with OM is lacking.To determine whether biofilm formation occurs in middle-ear (...) microscopy indicated that bacteria within the biofilms are viable.These preliminary findings provide evidence that mucosal biofilms form in an experimental model of otitis media and suggest that biofilm formation may be an important factor in the pathogenesis of chronic otitis media with effusion.

2002 JAMA

140. Pneumococcal vaccines for preventing otitis media. (PubMed)

Pneumococcal vaccines for preventing otitis media. Acute otitis media (AOM) is one of the most common diseases in early infancy and childhood. Long term effects of recurrent episodes of otitis media, rapid emergence of drug resistant bacteria associated with AOM worldwide and huge estimated direct and indirect annual costs associated with otitis media have emphasized the need for an effective vaccination program to prevent episodes of AOM.The object of this review was to assess the effect (...) in specific high-risk (otitis-prone) populations.

2002 Cochrane